In‑country availability of medical abortion medicines: a description of the framework and methodology of the WHO landscape assessments

Authors: Ulrika Rehnström Loi, Ndola Prata, Amy Grossman, Antonella Lavelanet, Natalie Williams, and Bela Ganatra

Read the full study here.

Previous
Previous

Availability of medical abortion medicines in eight countries: a descriptive analysis of key findings and opportunities

Next
Next

Green sex for climate's sake